Tvardi Therapeutics, Inc. (TVRD) stock
TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.18+0.02 (+2.16%)
Close on Nov 13, 2026Market cap $15.74MP/E –Yield 0.00%
Tvardi Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Tvardi Therapeutics's enterprise value was -$3.19M on Nov 11, 2026, against $2.18M a year earlier. Over the last 5 years it ranged from -$27.46M to $1.72B, with a median of $38.14M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$3.19M | -182.5% |
| 2025 | Dec 31, 2025 | $3.87M | -90.8% |
| 2024 | Dec 31, 2024 | $41.88M | +9.8% |
| 2023 | Dec 29, 2023 | $38.14M | -97.5% |
| 2022 | Dec 30, 2022 | $1.55B | -5.4% |
| 2021 | Dec 31, 2021 | $1.64B | -17.9% |
| 2020 | Dec 31, 2020 | $2.00B | -0.5% |
| 2019 | Dec 31, 2019 | $2.01B | +50.9% |
| 2018 | Dec 31, 2018 | $1.33B | +21.5% |
| 2017 | Dec 29, 2017 | $1.09B | +58.8% |
| 2016 | Dec 30, 2016 | $688.99M | -45.6% |
| 2015 | Dec 31, 2015 | $1.27B | +103.3% |
| 2014 | Dec 31, 2014 | $622.91M | – |
See a number that looks wrong?